Literature DB >> 14461900

Role of Serratia species in urinary tract infections.

L J LANCASTER.   

Abstract

Entities:  

Keywords:  SERRATIA/infection; URINARY TRACT INFECTIONS

Mesh:

Year:  1962        PMID: 14461900     DOI: 10.1001/archinte.1962.03620170034005

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  15 in total

1.  Bacto-TB hydrolysis reagent (Tween 80) for identification of Serratia.

Authors:  M Weiner
Journal:  J Clin Microbiol       Date:  1977-11       Impact factor: 5.948

2.  Gram-negative endotoxin shock due to Serratia marcescens.

Authors:  J N Henry; E W Gelfand; E J Hinchey
Journal:  Can Med Assoc J       Date:  1970-01-17       Impact factor: 8.262

3.  The increasing isolation of Serratia species from clinical specimens.

Authors:  H J Brooks; T J Chambers; S Tabaqchali
Journal:  J Hyg (Lond)       Date:  1979-02

4.  Antibiotic resistance in Serratia marcescens.

Authors:  J D Sleigh
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

5.  Serratia marcescens osteomyelitis in Cushing's disease.

Authors:  Hugo F G Martins; Alexandra Raposo; Isabel Baptista; Julio Almeida
Journal:  BMJ Case Rep       Date:  2015-11-30

6.  Hospital isolates of Serratia marcescens transferring ampicillin, carbenicillin, and gentamicin resistance to other gram-negative bacteria including Pseudomonas aeruginosa.

Authors:  V M Olexy; T J Bird; H G Grieble; S K Farrand
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

7.  Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.

Authors:  W H Traub; E A Raymond
Journal:  Appl Microbiol       Date:  1971-12

8.  Specific distribution of R factors in Serratia marcescens strains isolated from hospital infections.

Authors:  S Schaefler; J Winter; A Catelli; J Greene; B Toharski
Journal:  Appl Microbiol       Date:  1971-09

9.  Epidemiological and bacteriological investigation of Serratia marcescens epidemic in a nursery and in a neonatal intensive care unit.

Authors:  D Montanaro; G M Grasso; I Annino; N De Ruggiero; A Scarcella; F Schioppa
Journal:  J Hyg (Lond)       Date:  1984-08

10.  Caprylate-thallous agar medium for selectively isolating Serratia and its utility in the clinical laboratory.

Authors:  M P Starr; P A Grimont; F Grimont; P B Starr
Journal:  J Clin Microbiol       Date:  1976-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.